On Thursday, Marathon Oil Corporation (NYSE:MRO)’s shares inclined 1.70% to $12.59.
Team, Inc. (TISI) declared that Sylvia J. Kerrigan, 50, has been designated to the Team Board of Directors. Ms. Kerrigan is the Executive Vice President, General Counsel and Secretary of Marathon Oil Corporation (MRO) and has served in that position since 2012. From 2009 to 2012, Ms. Kerrigan served as Vice President, General Counsel and Secretary for Marathon Oil. Ms. Kerrigan will stand for re-election at Team’s forthcoming Annual Meeting of Shareholders in May 2016.
Team also declared that Sidney B. Williams, has informed Team of his intention to retire from the Team Board of Directors at the end of his current term. Mr. Williams has served with distinction on Team’s Board of Directors since the company’s inception for more than 40 years. Mr. Williams is the sole shareholder of a professional corporation which is a partner in the law firm of Chamberlain, Hrdlicka, White, Williams & Aughtry in Houston. Following his retirement from the Board, Mr. Williams will continue to be associated with Team as Director Emeritus.
Team’s Executive Chairman, Phil Hawk, said: “Team is indebted to Sid for his outstanding service to Team as a founding board member. On behalf of the entire Board, we express our sincere appreciation to Sid for his important contributions to Team’s success. We are also happy to welcome Sylvia Kerrigan to our Board. Sylvia has an extensive background in the energy industry and we believe we will benefit greatly from her expertise as Team continues to grow.”
Marathon Oil Corporation operates as an energy company. It operates in three segments: North America Exploration and Production, International Exploration and Production, and Oil Sands Mining. The North America Exploration and Production segment explores for, produces, and markets crude oil and condensate, natural gas liquids, and natural gas in North America.
Iconix Brand Group Inc (NASDAQ:ICON)’s shares gained 10.52% to $6.83. The last trading range of Iconix Brand Group Inc (NASDAQ:ICON) ranges between $6.12 and $6.99. The EPS of the company stands at $1.89. The 52-week range shows that the stock reached higher at $37.29 while its lower range is $5.34 in the last 52-weeks. The average volume of the company is at 2.67 million with the Outstanding Shares of 48.39 million. The market capitalization of the company is $330.53 billion. The Beta of the company stands at 1.90 with the RSI (Relative Strength Index) of 41.45.
Iconix Brand Group, Inc., a brand administration company, owns, licenses, and markets a portfolio of consumer brands across women’s, men’s, entertainment, and home primarily in the United States and internationally.
CEL-SCI Corporation (NYSEMKT:CVM)‘s shares surged 0.03% to $0.370. CEL-SCI Corporation (NYSEMKT:CVM) is now worth about $48.09 billion. The share price has made a -8.66% loss in the past 5 days and has lost -41.27% since 2015 kicked off. Analysts are forecasting EPS growth of -0.42% for next fiscal year. The stock trades with a beta of 0.19. The stock price is below by -45.57% as contrast to the average price over the last 200 days.
CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company’s lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. Multikine is also being used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, in addition to autoimmune diseases, allergies, transplantation rejections, and cancer.
